Navigation Links
National Psoriasis Foundation awards more than $2 million for research
Date:5/15/2012

PORTLAND, Ore. (May 15, 2012)Twenty-six scientists have received a total of $2.06 million in grants from the National Psoriasis Foundation to study psoriasisthe most common autoimmune disease in the country, affecting as many as 7.5 million Americansand psoriatic arthritis, an inflammatory joint and tendon disease.

  • Eight scientists each received a one-year, $50,000 Discovery Grant, for a total of $400,000, for pilot projects that have great potential to lead to breakthroughs in our understanding of psoriatic diseases and to discover better treatments. The grants are also intended to lay the groundwork for additional, long-term funding from the National Institutes of Health and other funding agencies. Learn about the National Psoriasis Foundation Discovery Grant recipients and their projects at www.psoriasis.org/grants/2012/discovery.

  • Six scientists each received a two-year, $200,000 Translational Grant, for a total of $1.2 million, for studies that aim to move laboratory and clinical discoveries into projects and treatments that benefit patients. Read about the Translational Research Grant recipients and their work at www.psoriasis.org/grants/2012/translational.

  • Twelve early-career dermatologists were awarded Psoriasis Foundation medical dermatology fellowships totaling $465,000. These fellowships provide support of up to $40,000 per year to new doctors training to do research in psoriasis and psoriatic arthritis. The fellowships are intended to increase the number of doctors studying psoriatic diseases. Meet the National Psoriasis Foundation Fellows at: www.psoriasis.org/grants/2012/fellowship.

"National Psoriasis Foundation is committed to funding promising research," said Chip Newton of the National Psoriasis Foundation's
'/>"/>

Contact: Catie Coman
media@psoriasis.org
503-546-8367
National Psoriasis Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Washington University receives $8 million to lead international childhood malnutrition effort
2. 2012 AAPS National Biotechnology Conference heads to San Diego
3. TGen leads new National Institutes of Health study of brain tumors
4. UC Santa Cruz builds national data center for cancer genome research
5. Harris Lewin elected to National Academy of Sciences
6. Medical device, health professionals attend first national conference on value-driven engineering
7. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
8. Ohio state hosts national energy conference
9. Southampton researchers lead 2 international projects to help people out of poverty
10. As deadly cat disease spreads nationally, MU veterinarian finds effective treatment
11. International team uncovers new genes that shape brain size, intelligence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... June 23, 2015  Crossmatch™, a leading ... today announced enhanced functionality of its DigitalPersona ... The enhancements build on the native flexibility ... Altus platform and provide expanded mobile credential ... In today,s environment of increasing cyber-attacks and ...
(Date:6/17/2015)... SAN JOSE, Calif. , June 17, 2015 ... leader in human interface solutions, today announced that ... has adopted the Synaptics ® ClearPad ® ... family of display driver integrated circuits (DDICs) for ... Note Pro. By leveraging ClearPad for full in-cell ...
(Date:6/16/2015)... Fingerprint Cards (FPC) raises the revenue ... amount to at least 340 MSEK to that it will ... in market growth and orders received the revenue guidance for ... for 2015 will exceed 1,500 MSEK to an updated guidance ... Due to receipt of orders of touch fingerprint ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
... of drugs used to treat parasitic infections such as malaria ... a new WSU-led study has found., Researchers discovered that simple ... its ability to affect specific human proteins involved in the ... how relatively simple the molecules are that we modified and ...
... is available in German . ... In the wild Arabidopsis thaliana uses the same ... its size in half as found in semi-dwarf varieties of rice and ... various plant species apparently fall back on the same genes in their ...
... Northwestern University Feinberg School of Medicine in Chicago, a ... led by Kezhong Zhang, Ph.D., has contributed to an ... inhibitor for the treatment of rheumatoid arthritis. The ... microbiology and Wayne State,s Center for Molecular Medicine and ...
Cached Biology News:Researcher finds potential new use for old drugs 2The secret of short stems 2The secret of short stems 3Wayne State researchers discover specific inhibitor for rheumatoid arthritis treatment 2
(Date:7/3/2015)... ... July 03, 2015 , ... The Alexander Group, ... professional service industries alike-- typically known for its consummate professionalism-- embarks each year ... cause and break from their day jobs. , "Our motto has always been ...
(Date:7/3/2015)... July 3, 2015 ... Open Innovation in Science", som finner sted ... sendes på nett, på  http://www.openinnovationinscience.at , og ... De to største utfordringene innen ... undersøke nye forskningsspørsmål og kompleksiteten av nåværende ...
(Date:7/2/2015)... ... 03, 2015 , ... Cuvettes have been used in countless labs for decades. In the ... they needed. As expected, this was a daunting and tiring process looking at endless ... were not able to navigate the complex catalog structure. , Now thanks to FireflySci, scientists ...
(Date:7/2/2015)... Scotland , July 2, 2015 ... Bio-tech procurement company Amici Procurement has chosen ... to help it move to Office 365. ... provides small to medium-sized companies in the bio-tech ... all aspects of the purchasing cycle to help them ...
Breaking Biology Technology:The Alexander Group Declares Their Independence with a Bit of Levity 2Lansering av verdens første Open Innovation-program for utdanning av forskere 2Lansering av verdens første Open Innovation-program for utdanning av forskere 3New Cuvette E-Commerce Website Launched by FireflySci 2Biotech Procurement Company Moves to Office 365 with iomart 2
... MGCD0103,s Orphan Drug, Designation for the Treatment of ... BOULDER, Colo. and MONTREAL, Sept. 24 ,Pharmion Corporation ... MYG) today,announced that the European Medicines Agency (EMEA) ... deacetylase (HDAC),inhibitor, as an Orphan Medicinal Product for ...
... September 24 Nitec Pharma AG today,announced that ... accepted the,Investigational New Drug (IND) application submitted by ... Following the positive results of a European ... Rheumatoid Arthritis), Nitec,submitted a dossier for marketing authorization ...
... of XYOTAX(R) for Women with ... Advanced Non-Small Cell Lung Cancer, SEATTLE, Sept. 24 Cell ... a confirmatory phase,III clinical trial of combination chemotherapy for women with ... women,today. The trial, known as PGT307, will focus exclusively on women ...
Cached Biology Technology:Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma 2Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma 3Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma 4Nitec's IND Application for Clinical Development With Lodotra Accepted by the FDA 2Nitec's IND Application for Clinical Development With Lodotra Accepted by the FDA 3Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer 2Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer 3Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer 4Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer 5
EZ-DeWax is a one-step solution that simultanously removes paraffin from and rehydrates formalin-fixed, paraffin embedded tissue...
... Gene Cycler unit is an inexpensive personal or ... the PCR process. Lightweight, with a small footprint, ... anywhere, including the researcher's desk. , The Gene ... who do not have access to a large ...
... Red fluorescent RNA stain is used to ... or glyoxal) agarose gels and does not ... a 302 nm transilluminator, the stain emits ... on Polaroid film or with a CCD ...
From the company that first brought you the chromatin immunoprecipitation (ChIP) kit, a new and improved kit, EZ-ChIP, is now available to make your experiments easier, quicker, and most importantly,...
Biology Products: